Among the >38,000 cases sequenced at Foundation One, EGFR KDD was detected in 5 out of approximately 7200 lung cancers (0.07%), 3 gliomas, 1 soft tissue sarcoma, 1 peritoneal serous carcinoma and 1 Wilms’ tumor [9]. This evidence concerns the gene EGFR and soft tissue sarcoma.